Quantitative Proteomics Reveals Novel Immunomodulatory Pathways of Resistance to PARP Therapy - Biognosys

Quantitative Proteomics Reveals Novel Immunomodulatory Pathways of Resistance to PARP Therapy

Posters

E-Poster presented at AACR 2020

Presenter: Kristina Beeler, PhD
A collaboration with: Cancer Research UK Cambridge Institute

Back to Resources overview

Contact

    Close banner

    New: Spectronaut® 19

    Unlock Your Data's True Story

    New: Spectronaut® 19

    Unlock Your Data's True Story

    Learn More